ACHV
NASDAQ · Biotechnology
Achieve Life Sciences Inc
$7.59
+0.34 (+4.69%)
Open$7.27
Previous Close$7.25
Day High$7.60
Day Low$7.15
52W High$7.34
52W Low$2.45
Volume—
Avg Volume1.25M
Market Cap725.46M
P/E Ratio—
EPS$-1.11
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+320.2% upside
Current
$7.59
$7.59
Target
$31.89
$31.89
$22.93
$31.89 avg
$41.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 55.20B | 99.77B | 656.40M |
| Net Income | -136,746,953 | -222,433,142 | 10.36M |
| Profit Margin | -397.8% | -377.9% | 1.6% |
| EBITDA | -137,336,051 | -235,802,003 | 18.53M |
| Free Cash Flow | — | — | 6.70M |
| Rev Growth | -44.7% | -44.7% | +1.9% |
| Debt/Equity | 0.69 | 0.69 | 0.12 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $258.92 | +3.43% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $425.28 | +1.41% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $143.44 | +3.25% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $528.19 | +2.45% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $810.24 | +0.53% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.61 | +1.79% | 37.6 | 30.39B |